Chemogenomic Profiling in Hematological Malignancies (HEM-Profiling 2021)

03 Mar 20264 min read0 viewsINTERVENTIONAL Trial

GIST

RECRUITING · INTERVENTIONAL · BASIC SCIENCE study · Chronic Leukemia · Enrollment 250 · Sponsor: Azienda Ospedaliero-Universitaria di Parma

Clinical Editorial

Summary

ClinicalTrials.gov published a clinical update in Oncology on 03 Mar 2026. The item focuses on Chemogenomic Profiling in Hematological Malignancies (HEM-Profiling 2021). Open the detail page to review the full original feed content.

Source Reference

Read the full original publication from the source journal or publisher link below.

DOI

NCT07445984

Open Original Source More Feed Items

Related by Condition/Drug

Br J CancerRelated by Conditionleukemia

SLIRP Maintains Mitochondrial mRNA Stability and OXPHOS in Colorectal Cancer

Oncology • 28 Apr 2026

ClinicalTrialsRelated by Conditionleukemia

Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)

Oncology • 06 Apr 2026

ClinicalTrialsRelated by Conditionleukemia

A Phase 1/2 Study of LBS-007 in Relapsed or Resistant Acute Leukaemias

Oncology • 27 Mar 2026

Nat Rev OncRelated by Conditionleukemia

A 2026 update on myelodysplastic neoplasms: current state, challenges and future directions

Oncology • 14 Apr 2026

Nat Rev OncRelated by Conditionleukemia

A 2026 update on myelodysplastic neoplasms: current state, challenges and future directions

Oncology • 14 Apr 2026

Br J CancerRelated by Conditionleukemia

Apoptotic Modulators Enhance Oncolytic Virus-Induced Cytokine Killing in Acute Myeloid Leukemia

Oncology • 10 Apr 2026

Feed Metadata

Source

ClinicalTrials.gov